Plus Therapeutics (PSTV) Debt Ratio (2010 - 2026)

Plus Therapeutics (PSTV) has 17 years of Debt Ratio data on file, last reported at 0.03 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.03, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03 (changed N/A YoY), and the FY2025 annual result was 0.05, down 90.74% from the prior year.
• Debt Ratio eased to 0.03 in Q1 2026 per PSTV's latest filing, from 0.05 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.64 in Q1 2024 and troughed at 0.03 in Q1 2026.
• A 5-year average of 0.31 and a median of 0.31 in 2023 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio soared 97.5% in 2024, then plunged 90.74% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.23 in 2022, then surged by 54.48% to 0.35 in 2023, then soared by 42.15% to 0.5 in 2024, then sank by 90.74% to 0.05 in 2025, then retreated by 27.1% to 0.03 in 2026.
• Business Quant data shows PSTV's Debt Ratio at 0.03 in Q1 2026, 0.05 in Q4 2025, and 0.5 in Q4 2024.